ENTBF (Entheon Biomedical) EBITDA Margin %: 0.00% (As of Feb. 2026)


What is Entheon Biomedical EBITDA Margin %?

Entheon Biomedical ENTBF EBITDA Margin % is 0.00% as of Feb. 2026. The stock has 2 warning signs investors should review. Among 944 Biotechnology companies, Entheon Biomedical ranks worse than 105932.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Entheon Biomedical's EBITDA for the three months ended in Feb. 2026 was $-0.07 Mil. Entheon Biomedical's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, Entheon Biomedical's EBITDA margin for the quarter that ended in Feb. 2026 was 0.00%.

Entheon Biomedical  (OTCPK:ENTBF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Entheon Biomedical EBITDA Margin % Related Terms

Entheon Biomedical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical EBITDA Margin % Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23 Nov24 Nov25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only 0.00 -1,896.45 -125.27 0.00 0.00

Entheon Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ENTBF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Entheon Biomedical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's EBITDA Margin % falls into.


Entheon Biomedical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Entheon Biomedical's EBITDA Margin % for the fiscal year that ended in Nov. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Nov. 2025 )/Revenue (A: Nov. 2025 )
=-0.238/0
= %

Entheon Biomedical's EBITDA Margin % for the quarter that ended in Feb. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.074/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Entheon Biomedical (ENTBF) has a EBITDA Margin % of 0.00% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Entheon Biomedical and its competitors. According to the industry distribution chart, Entheon Biomedical ranks #999999 out of 944 companies in the Biotechnology industry.
Is Entheon Biomedical's EBITDA Margin % too high?
Entheon Biomedical's current EBITDA Margin % is 0.00%. Based on the distribution chart, Entheon Biomedical ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Entheon Biomedical's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entheon Biomedical ranks #999999 out of 944 companies for EBITDA Margin %. This places Entheon Biomedical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current EBITDA Margin % is 0.00% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.